KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Leases (2019 - 2025)

Twist Bioscience (TWST) has disclosed Leases for 7 consecutive years, with $72.3 million as the latest value for Q4 2025.

  • Quarterly Leases rose 27.96% to $72.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.3 million through Dec 2025, up 27.96% year-over-year, with the annual reading at $49.4 million for FY2025, 16.07% down from the prior year.
  • Leases for Q4 2025 was $72.3 million at Twist Bioscience, up from $49.4 million in the prior quarter.
  • The five-year high for Leases was $78.2 million in Q1 2022, with the low at $31.0 million in Q1 2021.
  • Average Leases over 5 years is $64.1 million, with a median of $66.4 million recorded in 2023.
  • The sharpest move saw Leases skyrocketed 152.33% in 2022, then dropped 18.26% in 2024.
  • Over 5 years, Leases stood at $72.0 million in 2021, then grew by 2.41% to $73.8 million in 2022, then decreased by 6.32% to $69.1 million in 2023, then decreased by 18.26% to $56.5 million in 2024, then grew by 27.96% to $72.3 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $72.3 million, $49.4 million, and $51.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.